🎁 Black Friday: up to 50% off of annual plans
Concord Biotech Limited (BOM:543960)
India flag India · Delayed Price · Currency is INR
556.20
-4.85 (-0.86%)
At close: Nov 19, 2026

Concord Biotech Revenue

Concord Biotech had revenue of 3.09B INR in the quarter ending September 30, 2026, with 25.10% growth. This brings the company's total for the last twelve months to 11.70B, up 4.02% year-over-year. In the fiscal year ending March 31, 2026, Concord Biotech had annual revenue of 10.55B, down -12.10%.

Revenue (ttm)
11.70B
Revenue Growth
+4.02%
P/S Ratio
9.94
Revenue / Employee
7.21M
Employees
1,624
Market Cap
116.33B

Revenue Chart

Revenue by Geography

  • India 5.64B 53.4%
  • Others 3.83B 36.3%
  • America 1.08B 10.2%
Fiscal year ended Mar 31, 2026 See the full Concord Biotech breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202610.55B-1.45B-12.10%
Mar 31, 202512.00B1.83B18.01%
Mar 31, 202410.17B1.64B19.20%
Mar 31, 20238.53B1.40B19.67%
Mar 31, 20227.13B959.91M15.56%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Concord Biotech News

More News